KEGG   PATHWAY: pyu04934
Entry
pyu04934                    Pathway                                
Name
Cushing syndrome - Puma yagouaroundi (jaguarundi)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
pyu04934  Cushing syndrome
pyu04934

Organism
Puma yagouaroundi (jaguarundi) [GN:pyu]
Gene
121038177  CRH; corticoliberin [KO:K05256]
121020148  CRHR1; corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
121028523  CRHR2; corticotropin-releasing factor receptor 2 isoform X1 [KO:K04579]
121019943  guanine nucleotide-binding protein G(s) subunit alpha isoform X1 [KO:K04632]
121019944  neuroendocrine secretory protein 55 [KO:K04632]
121016977  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
121042416  ADCY2; adenylate cyclase type 2 isoform X1 [KO:K08042] [EC:4.6.1.1]
121044199  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
121031569  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
121036524  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
121038647  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
121045271  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
121042990  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
121019600  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
121014090  PRKACA; LOW QUALITY PROTEIN: cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
121027378  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
121030974  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
121030728  ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
121040318  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
121021362  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
121034643  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
121015682  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
121028276  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 isoform X1 [KO:K09048]
121043476  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
121028557  CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
121022388  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049]
121023668  MEN1; menin isoform X1 [KO:K14970]
121018583  ASH2L; set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1 [KO:K14964]
121021694  RBBP5; retinoblastoma-binding protein 5 isoform X1 [KO:K14961]
121036324  WDR5B; WD repeat-containing protein 5B [KO:K14963]
121024632  WD repeat-containing protein 5 [KO:K14963]
121035470  KMT2A; histone-lysine N-methyltransferase 2A [KO:K09186] [EC:2.1.1.354]
121038633  KMT2D; LOW QUALITY PROTEIN: histone-lysine N-methyltransferase 2D [KO:K09187] [EC:2.1.1.354]
121027105  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
121034524  cyclin-dependent kinase 4 inhibitor B [KO:K04685]
121034522  cyclin-dependent kinase inhibitor 2A-like [KO:K06621]
121040857  CDK4; cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
121028738  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
121023852  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
121012950  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
121012039  E2F1; transcription factor E2F1 [KO:K17454]
121023030  E2F2; transcription factor E2F2 [KO:K09389]
121020536  E2F3; transcription factor E2F3 [KO:K06620]
121015798  RASD1; dexamethasone-induced Ras-related protein 1 isoform X1 [KO:K07843]
121027636  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha-3 [KO:K04630]
121028803  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
121011233  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
121028662  AHR; aryl hydrocarbon receptor isoform X1 [KO:K09093]
121035824  aryl hydrocarbon receptor-like isoform X1 [KO:K09093]
121023884  AH receptor-interacting protein isoform X1 [KO:K17767]
121016081  AIPL1; aryl-hydrocarbon-interacting protein-like 1 isoform X1 [KO:K17767]
121021044  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
121038909  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
121040954  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
121042720  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
121011326  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
121029363  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
121022112  CACNA1C; voltage-dependent L-type calcium channel subunit alpha-1C isoform X1 [KO:K04850]
121016834  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D isoform X1 [KO:K04851]
121026060  CACNA1F; voltage-dependent L-type calcium channel subunit alpha-1F isoform X1 [KO:K04853]
121021720  CACNA1S; voltage-dependent L-type calcium channel subunit alpha-1S isoform X1 [KO:K04857]
121045049  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
121036802  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
121016945  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
121030635  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
121027680  RAP1A; ras-related protein Rap-1A isoform X1 [KO:K04353]
121040776  RAP1B; ras-related protein Rap-1b [KO:K07836]
121028241  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
121041863  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
121021465  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
121022226  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
121023018  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
121038550  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
121017018  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
121041689  USP8; ubiquitin carboxyl-terminal hydrolase 8 [KO:K11839] [EC:3.4.19.12]
121044205  POMC; pro-opiomelanocortin [KO:K05228]
121032683  MC2R; adrenocorticotropic hormone receptor [KO:K04200]
121036009  melanocortin-2 receptor accessory protein [KO:K22398]
121014173  PDE8B; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1 [KO:K18437] [EC:3.1.4.53]
121042335  PDE8A; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X1 [KO:K18437] [EC:3.1.4.53]
121030756  PDE11A; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform X1 [KO:K13298] [EC:3.1.4.17 3.1.4.35]
121034975  NR5A1; steroidogenic factor 1 [KO:K08560]
121038490  SP1; transcription factor Sp1 [KO:K04684]
121020871  PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355]
121024468  cytochrome P450 11B1, mitochondrial-like [KO:K00497] [EC:1.14.15.4]
121043245  cytochrome P450 11B1, mitochondrial isoform X1 [KO:K00497] [EC:1.14.15.4]
121037171  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
121019179  STAR; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
121034001  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]
121022991  ARMC5; armadillo repeat-containing protein 5 isoform X1 [KO:K22499]
121023141  AGT; angiotensinogen [KO:K09821]
121033803  AGTR1; type-1 angiotensin II receptor [KO:K04166]
121013601  guanine nucleotide-binding protein G(q) subunit alpha isoform X1 [KO:K04634]
121021509  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
121012476  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
121012479  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
121023937  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
121041495  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
121041326  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
121038795  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1 [KO:K04959]
121029298  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1 [KO:K04960]
121011790  KCNK2; potassium channel subfamily K member 2 isoform X1 [KO:K04913]
121044785  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
121019340  CACNA1H; voltage-dependent T-type calcium channel subunit alpha-1H [KO:K04855]
121040314  CACNA1I; voltage-dependent T-type calcium channel subunit alpha-1I [KO:K04856]
121010462  ORAI1; calcium release-activated calcium channel protein 1 [KO:K16056]
121043617  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
121044515  KCNK3; potassium channel subfamily K member 3 [KO:K04914]
121013997  LDLR; low-density lipoprotein receptor isoform X1 [KO:K12473]
121010123  SCARB1; scavenger receptor class B member 1 [KO:K13885]
121041978  cholesterol side-chain cleavage enzyme, mitochondrial isoform X1 [KO:K00498] [EC:1.14.15.6]
121027796  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase [KO:K00070] [EC:1.1.1.145 5.3.3.1]
121022330  steroid 21-hydroxylase isoform X1 [KO:K00513] [EC:1.14.14.16]
121015095  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
121038637  WNT1; proto-oncogene Wnt-1 [KO:K03209]
121027695  WNT2B; protein Wnt-2b [KO:K00182]
121028442  WNT2; protein Wnt-2 [KO:K00182]
121016686  WNT3A; protein Wnt-3a [KO:K00312]
121020143  WNT3; proto-oncogene Wnt-3 isoform X1 [KO:K00312]
121022836  WNT4; protein Wnt-4 [KO:K00408]
121022123  WNT5B; protein Wnt-5b [KO:K00444]
121016831  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
121031083  WNT6; protein Wnt-6 [KO:K00445]
121040175  WNT7B; protein Wnt-7b [KO:K00572]
121041205  WNT7A; protein Wnt-7a [KO:K00572]
121037468  WNT8B; protein Wnt-8b [KO:K00714]
121010888  WNT8A; protein Wnt-8a [KO:K00714]
121016685  WNT9A; protein Wnt-9a isoform X1 [KO:K01064]
121020160  WNT9B; protein Wnt-9b [KO:K01064]
121031082  WNT10A; protein Wnt-10a [KO:K01357]
121038640  WNT10B; protein Wnt-10b [KO:K01357]
121039303  WNT11; protein Wnt-11 [KO:K01384]
121028423  WNT16; protein Wnt-16 [KO:K01558]
121030921  FZD7; frizzled-7 isoform X1 [KO:K02432]
121027988  FZD1; frizzled-1 [KO:K02432]
121045102  FZD2; frizzled-2 [KO:K02235]
121024748  FZD3; frizzled-3 isoform X1 [KO:K02329]
121039382  FZD4; frizzled-4 isoform X1 [KO:K02354]
121030981  FZD5; frizzled-5 [KO:K02375]
121014548  FZD8; frizzled-8 [KO:K02375]
121042823  FZD6; frizzled-6 [KO:K02376]
121024259  FZD10; frizzled-10 [KO:K02842]
121017718  FZD9; frizzled-9 [KO:K02842]
121016029  DVL2; LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
121019071  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
121034071  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
121036286  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
121019790  AXIN1; axin-1 isoform X1 [KO:K02157]
121015318  AXIN2; axin-2 [KO:K04385]
121033506  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
121011897  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
121021383  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
121010702  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
121019121  TCF7L1; transcription factor 7-like 1 [KO:K04490]
121037238  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
121031433  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
pyu00020  Citrate cycle (TCA cycle)
pyu00140  Steroid hormone biosynthesis
pyu04020  Calcium signaling pathway
pyu04024  cAMP signaling pathway
pyu04110  Cell cycle
pyu04310  Wnt signaling pathway
pyu04927  Cortisol synthesis and secretion
pyu04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system